Novel drugs stop influenza replication
Influenza viruses are responsible for the seasonal flu, affecting millions of people worldwide every year. Given the potential of influenza to cause pandemics with devastating effects on human lives and the economy, there is a pressing need for effective antiviral drugs with a reduced risk of causing viral escape. Scientists of the EU-funded FluAttack project have identified a new family of molecules as potent inhibitors of influenza viruses. These molecules target a cellular function paramount to virus survival and will undergo further testing and characterisation in models of influenza infection. The project aims to support the future development and pre-clinical validation of these anti-flu drugs.
Fields of science
Call for proposal
See other projects for this call